Bratislava, Slovakia

Eva Veverkova

This inventor holds 1 USPTO granted patent. Top assignee: Zentiva K.s.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Veverkova. Retrieved from https://idiyas.com/inventor/eva-veverkova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Veverkova: Innovator in Pharmaceutical Manufacturing

Introduction

Eva Veverkova is a notable inventor based in Bratislava, Slovakia. She has made significant contributions to the field of pharmaceutical manufacturing, particularly in the development of methods for producing important compounds.

Latest Patents

Eva Veverkova holds a patent for a method of manufacturing crystalline form I of clopidogrel hydrogen sulphate. This innovative method involves the separation of clopidogrel from a solution in the form of its free base or salt, utilizing a solvent selected from primary, secondary, or tertiary C1-C5 alcohols, their esters with C1-C4 carboxylic acids, or mixtures thereof.

Career Highlights

Eva is currently employed at Zentiva, a prominent pharmaceutical company. Her work focuses on enhancing the efficiency and effectiveness of drug manufacturing processes. With her expertise, she has contributed to advancements in the production of critical medications.

Collaborations

Throughout her career, Eva has collaborated with several professionals, including Miroslav Veverka and Stefan Vodny. These collaborations have fostered a productive environment for innovation and development in the pharmaceutical sector.

Conclusion

Eva Veverkova's contributions to pharmaceutical manufacturing exemplify her dedication to innovation and improvement in drug production methods. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…